{"version":"1.0","type":"link","title":"Long-term progression-free survival with first-line pyrotinib monotherapy in a treatment-naïve stage IV NSCLC patient harboring an ERBB2 exon 20 insertion: a case report.","author_name":"Ke Z 외","author_url":"https://prs-insight.online/author/Ke%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/100462","thumbnail_width":1200,"thumbnail_height":630}